157 related articles for article (PubMed ID: 22969839)
1. Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer.
Nakayama Y; Torigoe T; Inoue Y; Minagawa N; Izumi H; Kohno K; Yamaguchi K
Exp Ther Med; 2012 Jan; 3(1):25-30. PubMed ID: 22969839
[TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of the expression of monocarboxylate transporter 4 in patients with right- or left-sided colorectal cancer.
Abe Y; Nakayama Y; Katsuki T; Inoue Y; Minagawa N; Torigoe T; Higure A; Sako T; Nagata N; Hirata K
Asia Pac J Clin Oncol; 2019 Apr; 15(2):e49-e55. PubMed ID: 30270512
[TBL] [Abstract][Full Text] [Related]
3. High monocarboxylate transporter 4 protein expression in stromal cells predicts adverse survival in gastric cancer.
Yan P; Li YH; Tang ZJ; Shu X; Liu X
Asian Pac J Cancer Prev; 2014; 15(20):8923-9. PubMed ID: 25374230
[TBL] [Abstract][Full Text] [Related]
4. Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.
Gotanda Y; Akagi Y; Kawahara A; Kinugasa T; Yoshida T; Ryu Y; Shiratsuchi I; Kage M; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2941-7. PubMed ID: 23780984
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
6. Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.
Doyen J; Trastour C; Ettore F; Peyrottes I; Toussant N; Gal J; Ilc K; Roux D; Parks SK; Ferrero JM; Pouysségur J
Biochem Biophys Res Commun; 2014 Aug; 451(1):54-61. PubMed ID: 25058459
[TBL] [Abstract][Full Text] [Related]
7. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors.
Hiltunen N; Rintala J; Väyrynen JP; Böhm J; Karttunen TJ; Huhta H; Helminen O
Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626155
[TBL] [Abstract][Full Text] [Related]
8. Expression of lactate/H⁺ symporters MCT1 and MCT4 and their chaperone CD147 predicts tumor progression in clear cell renal cell carcinoma: immunohistochemical and The Cancer Genome Atlas data analyses.
Kim Y; Choi JW; Lee JH; Kim YS
Hum Pathol; 2015 Jan; 46(1):104-12. PubMed ID: 25456395
[TBL] [Abstract][Full Text] [Related]
9. Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma.
Liu Y; Sun X; Huo C; Sun C; Zhu J
Med Sci Monit; 2019 Jun; 25():4278-4284. PubMed ID: 31177263
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.
Cheng B; Chen X; Li Y; Huang X; Yu J
Oncol Rep; 2018 Nov; 40(5):2906-2915. PubMed ID: 30226548
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Significance of Mitochondrial Transcription Factor A Expression in Patients with Right- or Left-sided Colorectal Cancer.
Katsuki T; Nakayama Y; Akiyama M; Sawatsubashi Y; Nagata J; Minagawa N; Torigoe T; Izumi H; Kohono K; Hirata K
Anticancer Res; 2018 Jan; 38(1):569-575. PubMed ID: 29277826
[TBL] [Abstract][Full Text] [Related]
12. Monocarboxylate transporters MCT1 and MCT4 are independent prognostic biomarkers for the survival of patients with clear cell renal cell carcinoma and those receiving therapy targeting angiogenesis.
Cao YW; Liu Y; Dong Z; Guo L; Kang EH; Wang YH; Zhang W; Niu HT
Urol Oncol; 2018 Jun; 36(6):311.e15-311.e25. PubMed ID: 29657088
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of mitochondrial transcription factor A expression in patients with colorectal cancer.
Nakayama Y; Yamauchi M; Minagawa N; Torigoe T; Izumi H; Kohno K; Yamaguchi K
Oncol Rep; 2012 May; 27(5):1325-30. PubMed ID: 22266811
[TBL] [Abstract][Full Text] [Related]
14. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
15. MCT4 has a potential to be used as a prognostic biomarker - a systematic review and meta-analysis.
Javaeed A; Ghauri SK
Oncol Rev; 2019 Jul; 13(2):403. PubMed ID: 31410246
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma.
Ohno A; Yorita K; Haruyama Y; Kondo K; Kato A; Ohtomo T; Kawaguchi M; Marutuska K; Chijiiwa K; Kataoka H
Liver Int; 2014 Jul; 34(6):942-52. PubMed ID: 24433439
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.
Huhta H; Helminen O; Palomäki S; Kauppila JH; Saarnio J; Lehenkari PP; Karttunen TJ
Oncotarget; 2017 Apr; 8(14):22894-22902. PubMed ID: 28206968
[TBL] [Abstract][Full Text] [Related]
18. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
[TBL] [Abstract][Full Text] [Related]
19. MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.
Kim HK; Lee I; Bang H; Kim HC; Lee WY; Yun SH; Lee J; Lee SJ; Park YS; Kim KM; Kang WK
Mol Cancer Ther; 2018 Apr; 17(4):838-848. PubMed ID: 29483215
[TBL] [Abstract][Full Text] [Related]
20. Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: spatial distribution and prognostic value of GLUT1 and MCT4.
Meijer TW; Schuurbiers OC; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; Verhagen AF; Lok J; van der Heijden HF; Rademakers SE; Span PN; Bussink J
Lung Cancer; 2012 Jun; 76(3):316-23. PubMed ID: 22153830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
